MarketScreener Strategies Vertex Pharmaceuticals Incorporated
Stocks
VRTX
US92532F1003
Pharmaceuticals
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 478.70 USD | +1.70% |
|
-2.38% | +5.59% |
| 08-04 | Vertex Pharmaceuticals Seen Well Positioned Ahead of Pipeline Catalysts, UBS Says | MT |
| 08-04 | Vertex Pharmaceuticals' Solid Q2, Raised Outlook Underscore Core Business Strength, RBC Says | MT |
MarketScreener Strategies
Search
 | Vertex Pharmaceuticals Incorporated : Vertex and Crispr to market $2.2 million treatment for sickle cell disease | December 11, 2023 at 02:47 pm |
 | Vertex Pharmaceuticals Incorporated : Confirms growth trajectory | May 04, 2023 at 05:35 pm |
 | Vertex Pharmaceuticals : A very promising pipeline | January 11, 2023 at 02:20 pm |
No results match your criteria
- Stock Market
- Stocks
- VRTX Stock
- News Vertex Pharmaceuticals Incorporated
- MarketScreener Strategies
Select your edition
All financial news and data tailored to specific country editions
